Terms: = Germ cell tumor AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Treatment
10 results:
1. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
Wong P; Wisneski AD; Tsai KK; Chang TT; Hirose K; Nakakura EK; Daud AI; Maker AV; Corvera CU
World J Surg Oncol; 2024 Mar; 22(1):77. PubMed ID: 38468341
[TBL] [Abstract] [Full Text] [Related]
2. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.
Gordon K; Gulidov I; Koryakin S; Smyk D; Makeenkova T; Gogolin D; Lepilina O; Golovanova O; Semenov A; Dujenko S; Medvedeva K; Mardynsky Y
Radiat Oncol; 2021 Dec; 16(1):238. PubMed ID: 34930352
[TBL] [Abstract] [Full Text] [Related]
3. Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1.
Ferreira WAS; Amorim CKN; Burbano RR; Villacis RAR; Marchi FA; Medina TS; Lima MMC; Oliveira EHC
Braz J Med Biol Res; 2021; 54(3):e9571. PubMed ID: 33470396
[TBL] [Abstract] [Full Text] [Related]
4. Biosynthetic CircRNA_001160 induced by PTBP1 regulates the permeability of BTB via the CircRNA_001160/miR-195-5p/etv1 axis.
Li H; Shen S; Ruan X; Liu X; Zheng J; Liu Y; Yang C; Wang D; Liu L; Ma J; Ma T; Wang P; Cai H; Li Z; Zhao L; Xue Y
Cell Death Dis; 2019 Dec; 10(12):960. PubMed ID: 31862871
[TBL] [Abstract] [Full Text] [Related]
5. A novel PTPRZ1-etv1 fusion in gliomas.
Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
[TBL] [Abstract] [Full Text] [Related]
6. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
[TBL] [Abstract] [Full Text] [Related]
7. The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis.
Kollareddy M; Sherrard A; Park JH; Szemes M; Gallacher K; Melegh Z; Oltean S; Michaelis M; Cinatl J; Kaidi A; Malik K
Cancer Lett; 2017 Sep; 403():74-85. PubMed ID: 28602975
[TBL] [Abstract] [Full Text] [Related]
8. Rare association of adrenal tumors.
Tica I; Tica VI; Mihailov C
Rom J Intern Med; 2007; 45(1):107-11. PubMed ID: 17966451
[TBL] [Abstract] [Full Text] [Related]
9. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract] [Full Text] [Related]
10. Pediatric brachytherapy. The St. Jude Children's Research Hospital experience.
Fontanesi J; Rao BN; Fleming ID; Bowman LC; Pratt CB; Furman WL; Coffey DH; Kun LE
Cancer; 1994 Jul; 74(2):733-9. PubMed ID: 8033055
[TBL] [Abstract] [Full Text] [Related]
